Glycaemic control in paediatric critical care

The Lancet

Volumn 373, Issue 9673, 2009, Pages 1423-

  Zuurbier, Coert J ^a   Bos, Albert P ^a   van Wezel, Harry B ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT;

ARTIFICIAL VENTILATION; CHILD CARE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INTENSIVE CARE; LETTER; MEDICAL PRACTICE; PRIORITY JOURNAL; BLOOD; CHILD; HYPERGLYCEMIA; METABOLISM; NOTE;

BLOOD GLUCOSE; CHILD; CRITICAL CARE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN;

EID: 64949128192     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)60812-6     Document Type: Letter

References (5)

1. Vlasselaers D., Milants I., Desmet L., et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet 373 (2009) 547-556
2. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 345 (2001) 1359-1367
3. Wiener R.S., Wiener D.C., and Larson R.J. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 300 (2008) 933-944
4. El-Osta A., Brasacchio D., Yao D., et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 205 (2008) 2409-2417
5. Faustino E.V., and Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr 146 (2005) 30-34